Universal eryhrodermia, KELA reimbursement

MESH PheWeb

L12_ERYTHRO_KELA

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

KELA reimbursements: KELA codes 134

280

Check pre-conditions, main-only, mode, ICD version None

280

Check minimum number of events None

280

Include endpoints None

280

L12_ERYTHRO_KELA

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Universal eryhrodermia, KELA reimbursement based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	270	98	172
Unadjusted prevalence (%)	0.09	0.06	0.13
Mean age at first event (years)	48.16	45.28	49.80

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: L12_ERYTHRO_KELA – Universal eryhrodermia, KELA reimbursement
GWS hits: 2

Survival analyses between endpoints

↥

Plot

before Universal eryhrodermia, KELA reimbursement
after Universal eryhrodermia, KELA reimbursement

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Universal eryhrodermia, KELA reimbursement

↥